Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Venteny Fortuna International Tbk. (VTNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Venteny Fortuna International Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Venteny Fortuna International Tbk. trades at Rp72 (market cap 476.15B, 21.68M 24h volume). The key difference: Venteny Fortuna International Tbk. is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Venteny Fortuna International Tbk. is more actively traded (21.68M versus 324K). Which is the better fit depends on your goals.
| OBAT | VTNY | |
|---|---|---|
Market Cap | 166.01B | 476.15B |
Volume | 324K | 21.68M |
Lot | 3.24K | 216.81K |
Turnover | 77.68M | 1.59B |
Average Price | 239.75 | 73.22 |
Value | 77.68M | 1.59B |
Indicative Equilibrium Price | 240 | 72 |
Indicative Equilibrium Volume | 1 | 4.89K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Venteny Fortuna International Tbk.
PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Read more on VTNY →
